Firms

Nordic Science Investments

Nordic Science Investments

Nordic Science Investments is a Finnish venture capital manager backing university spinouts and early-stage science-based companies across the Nordic and Baltic region. It specialises in pre-seed commercialisation of research in deep technology, health technology and life sciences, including neuroplasticity drug development, AI-driven systems, semiconductors, advanced materials, and synthetic biology. The team works with universities and founders on technology transfer, business development, recruiting teams, strategic guidance, and later financing, with follow-on capacity through Series B. Its legal manager is Nordic Science Investments Oy; Taaleri acquired a51% ownership stake in April2026, while the founders retained operational roles.

Founded
2022
Type
Venture capital

Funds1

  • NSI Nordic Science I Ky€45M

    Debut science-based university-spinout fund. The earliest verified dated first-close announcement is March5,2024; its exact first-close corpus was not disclosed. The original EUR60M and later EUR80M figures were fundraising targets. Taaleri’s April2026 primary disclosures confirm the same fund ultimately closed at EUR45M in late2025; the exact final-close day remains unknown. The amount records the latest confirmed final corpus, not the first-close size or a new April2026 raise.

Team

Operations and support

Alexandra GylfeFounding Partner
Anssi UimonenFounding Partner
Gerard de BourbonVenture Partner
Jari StrandmanCEO and Founding Partner
Mart MaasikGeneral Partner and Investment Committee Member
Matti HautsaloFounding Partner

Co-investing

BSV Ventures
Harjavalta Ventures
Specialist VC

Investments